Acute experimental pain responses in methadone- and buprenorphine/naloxone-maintained patients administered additional opioid or gabapentin: a double-blind crossover pilot study

- Murnion, Bridin Patricia, Rivas, Consuelo, Demirkol, Apo, Hayes, Vicky, Lintzeris, Nicholas, Nielsen, Suzanne

Buprenorphine not detected on urine drug screening in supervised treatment

- Jamshidi, Nazila, Athavale, Akshay, Murnion, Bridin

Correlates of pain in an in-treatment sample of opioid-dependent people

- Nielsen, Suzanne, Larance, Briony, Lintzeris, Nicholas, Black, Emma, Bruno, Raimondo, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa

Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial

- Dunlop, Adrian J., Dunlop, AJ, Brown, AL, Oldmeadow, C, Attia, J, Harris, A, Ghijben, P, Sadler, C, Bell, J, Lintzeris, N, Brown, Amanda L., Hinman, Jennifer, Jackson, Melissa, Bell, James, Lintzeris, Nicholas, Oldmeadow, Christopher, Harris, Anthony, Gill, Anthony, Sadler, Craig, Ribbons, Karen, Attia, John, Barker, Daniel, Ghijben, Peter

Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment

- Hallinan, Richard, Byrne, Andrew, Agho, Kingsley, McMahon, Chris, Tynan, Philip, Attia, John

High-dose methadone transfer to buprenorphine in outpatient settings

- Naumovski, Branko, Batey, Robert G.

Hypogonadism in men receiving methadone and buprenorphine maintenance treatment

- Hallinan, R., Byrne, A., Agho, K., McMahon, C. G., Tynan, P., Attia, J.

Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder

- Frost, Michael, Bailey, Genie L., Oosman, Sonia, Kim, Sonnie, Tiberg, Fredrik, Lintzeris, Nicholas, Strang, John, Dunlop, Adrian, Nunes, Edward V., Jansen, Jakob Billeskov, Frey, Lars Chemnitz, Weber, Bernd, Haber, Pauk

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

- Farrell, Michael, Shahbazi, Jeyran, Byrne, Marianne, Grebely, Jason, Lintzeris, Nicholas, Chambers, Mark, Larance, Briony, Ali, Robert, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Nicholas, Thomas, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa

Patient-centredness and opioid substitution

- Dunlop, Adrian

QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings

- Isbister, Geoffrey K., Brown, Amanda L., Gill, Anthony, Scott, Alexander J., Calver, Leonie, Dunlop, Adrian J.

Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia

- Barnett, Anthony, Savic, Michael, Lintzeris, Nicholas, Bathish, Ramez, Arunogiri, Shalini, Dunlop, Adrian J., Haber, Paul, Graham, Robert, Hayes, Vicky, Lubman, Dan I.

Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence

- Nielsen, Suzanne, Lintzeris, Nicholas, Dunlop, Adrian, Demirkol, Apo, Silsbury, Catherine, Phung, Nghi, Houseman, Jennie, Larance, Briony, Murnion, Bridin, Degenhardt, Louisa, Bruno, Raimondo, Haber, Paul, Johnson, Jennifer, Hardy, Mark, Ling, Stephen, Saddler, Craig